Larvol Delta - Araris-Biotech-AG-and-Taiho-Oncology-Announce-Dosing-of-First-Patient-in-Phase-1-Trial-of-ARC02-a-Novel-ADC-for-the-Treatment-of-NonHodgkin-Lymphoma

ARC-02 - Araris Biotech, Taiho Pharma

https://www.businesswire.com/news/home/20260623627184/en/Araris-Biotech-AG-and-Taiho-Oncology-Announce-Dosing-of-First-Patient-in-Phase-1-Trial-of-ARC-02-a-Novel-ADC-for-the-Treatment-of-Non-Hodgkin-Lymphoma

Jun 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next